Literature DB >> 22571595

Stem cell sources for vascular tissue engineering and regeneration.

Vivek K Bajpai1, Stelios T Andreadis.   

Abstract

This review focuses on the stem cell sources with the potential to be used in vascular tissue engineering and to promote vascular regeneration. The first clinical studies using tissue-engineered vascular grafts are already under way, supporting the potential of this technology in the treatment of cardiovascular and other diseases. Despite progress in engineering biomaterials with the appropriate mechanical properties and biological cues as well as bioreactors for generating the correct tissue microenvironment, the source of cells that make up the vascular tissues remains a major challenge for tissue engineers and physicians. Mature cells from the tissue of origin may be difficult to obtain and suffer from limited proliferative capacity, which may further decline as a function of donor age. On the other hand, multipotent and pluripotent stem cells have great potential to provide large numbers of autologous cells with a great differentiation capacity. Here, we discuss the adult multipotent as well as embryonic and induced pluripotent stem cells, their differentiation potential toward vascular lineages, and their use in engineering functional and implantable vascular tissues. We also discuss the associated challenges that need to be addressed in order to facilitate the transition of this technology from the bench to the bedside.

Entities:  

Mesh:

Year:  2012        PMID: 22571595      PMCID: PMC3458622          DOI: 10.1089/ten.TEB.2011.0264

Source DB:  PubMed          Journal:  Tissue Eng Part B Rev        ISSN: 1937-3368            Impact factor:   6.389


  299 in total

Review 1.  Clinical and biological relevance of vein cuff anastomosis.

Authors:  G Steinthorsson; B Sumpio
Journal:  Acta Chir Belg       Date:  1999-12       Impact factor: 1.090

2.  Fibrin-polylactide-based tissue-engineered vascular graft in the arterial circulation.

Authors:  Sabine Koch; Thomas C Flanagan; Joerg S Sachweh; Fadwa Tanios; Heike Schnoering; Thorsten Deichmann; Ville Ellä; Minna Kellomäki; Nina Gronloh; Thomas Gries; René Tolba; Thomas Schmitz-Rode; Stefan Jockenhoevel
Journal:  Biomaterials       Date:  2010-03-20       Impact factor: 12.479

Review 3.  At the stem of youth and health.

Authors:  Antonio Paolo Beltrami; Daniela Cesselli; Carlo Alberto Beltrami
Journal:  Pharmacol Ther       Date:  2010-10-20       Impact factor: 12.310

4.  Isolation and transcription profiling of purified uncultured human stromal stem cells: alteration of gene expression after in vitro cell culture.

Authors:  Andrew C Boquest; Aboulghassem Shahdadfar; Katrine Frønsdal; Olafur Sigurjonsson; Siv H Tunheim; Philippe Collas; Jan E Brinchmann
Journal:  Mol Biol Cell       Date:  2005-01-05       Impact factor: 4.138

5.  Efficient differentiation of hESCs into endothelial cells in vitro is secured by epigenetic changes.

Authors:  Maria A Lagarkova; Pavel Y Volchkov; Elena S Philonenko; Sergei L Kiselev
Journal:  Cell Cycle       Date:  2008-09-15       Impact factor: 4.534

6.  Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors.

Authors:  M Peichev; A J Naiyer; D Pereira; Z Zhu; W J Lane; M Williams; M C Oz; D J Hicklin; L Witte; M A Moore; S Rafii
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

7.  The role of matrix metalloproteinase-2 in the remodeling of cell-seeded vascular constructs subjected to cyclic strain.

Authors:  D Seliktar; R M Nerem; Z S Galis
Journal:  Ann Biomed Eng       Date:  2001-11       Impact factor: 3.934

8.  Differentiation of endothelial progenitor cells from human umbilical cord blood CD 34+ cells in vitro.

Authors:  Chun-Ling Fan; Yan Li; Ping-Jin Gao; Jian-Jun Liu; Xue-Jun Zhang; Ding-Liang Zhu
Journal:  Acta Pharmacol Sin       Date:  2003-03       Impact factor: 6.150

9.  In vivo assessment of a tissue-engineered vascular graft combining a biodegradable elastomeric scaffold and muscle-derived stem cells in a rat model.

Authors:  Alejandro Nieponice; Lorenzo Soletti; Jianjun Guan; Yi Hong; Burhan Gharaibeh; Timothy M Maul; Johnny Huard; William R Wagner; David A Vorp
Journal:  Tissue Eng Part A       Date:  2010-04       Impact factor: 3.845

10.  Human umbilical cord cells for cardiovascular tissue engineering: a comparative study.

Authors:  Alexander Kadner; Gregor Zund; Christine Maurus; Christian Breymann; Sidika Yakarisik; Gregor Kadner; Marko Turina; Simon P Hoerstrup
Journal:  Eur J Cardiothorac Surg       Date:  2004-04       Impact factor: 4.191

View more
  28 in total

1.  NANOG Restores Contractility of Mesenchymal Stem Cell-Based Senescent Microtissues.

Authors:  Aref Shahini; Panagiotis Mistriotis; Mohammadnabi Asmani; Ruogang Zhao; Stelios T Andreadis
Journal:  Tissue Eng Part A       Date:  2017-02-28       Impact factor: 3.845

Review 2.  Stem Cell Sources and Graft Material for Vascular Tissue Engineering.

Authors:  Dorothee Hielscher; Constanze Kaebisch; Benedikt Julius Valentin Braun; Kevin Gray; Edda Tobiasch
Journal:  Stem Cell Rev Rep       Date:  2018-10       Impact factor: 5.739

3.  Patterning of Fibroblast and Matrix Anisotropy within 3D Confinement is Driven by the Cytoskeleton.

Authors:  Janna V Serbo; Scot Kuo; Shawna Lewis; Matthew Lehmann; Jiuru Li; David H Gracias; Lewis H Romer
Journal:  Adv Healthc Mater       Date:  2015-06-01       Impact factor: 9.933

4.  Patient-specific cardiovascular progenitor cells derived from integration-free induced pluripotent stem cells for vascular tissue regeneration.

Authors:  Jiang Hu; Yongyu Wang; Jiao Jiao; Zhongning Liu; Chao Zhao; Zhou Zhou; Zhanpeng Zhang; Kaitlynn Forde; Lunchang Wang; Jiangang Wang; David J Baylink; Xiao-Bing Zhang; Shaorong Gao; Bo Yang; Y Eugene Chen; Peter X Ma
Journal:  Biomaterials       Date:  2015-09-11       Impact factor: 12.479

5.  The third annual BRDS on research and development of nucleic acid-based nanomedicines.

Authors:  Amit Kumar Chaudhary; Ram I Mahato
Journal:  Drug Deliv Transl Res       Date:  2017-02       Impact factor: 4.617

Review 6.  Building Blood Vessels with Vascular Progenitor Cells.

Authors:  Thomas Colunga; Stephen Dalton
Journal:  Trends Mol Med       Date:  2018-05-22       Impact factor: 11.951

Review 7.  Stem cell-derived vasculature: A potent and multidimensional technology for basic research, disease modeling, and tissue engineering.

Authors:  Justin Lowenthal; Sharon Gerecht
Journal:  Biochem Biophys Res Commun       Date:  2015-09-30       Impact factor: 3.575

Review 8.  Small-diameter vascular tissue engineering.

Authors:  Dawit G Seifu; Agung Purnama; Kibret Mequanint; Diego Mantovani
Journal:  Nat Rev Cardiol       Date:  2013-05-21       Impact factor: 32.419

9.  Engineering vascular tissue with functional smooth muscle cells derived from human iPS cells and nanofibrous scaffolds.

Authors:  Yongyu Wang; Jiang Hu; Jiao Jiao; Zhongning Liu; Zhou Zhou; Chao Zhao; Lung-Ji Chang; Y Eugene Chen; Peter X Ma; Bo Yang
Journal:  Biomaterials       Date:  2014-07-29       Impact factor: 12.479

10.  Biological and engineering design considerations for vascular tissue engineered blood vessels (TEBVs).

Authors:  Cristina E Fernandez; Hardean E Achneck; William M Reichert; George A Truskey
Journal:  Curr Opin Chem Eng       Date:  2014-02-01       Impact factor: 5.163

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.